Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 27, 2026 08:30 ET | Source: Jyong Biotech Ltd.

Jyong Biotech Updates the Potential Clinical Benefits and Advantages of Its Plant-Derived Innovative Drug MCS®-2

New Taipei City, Taiwan, March 27, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the development...
March 27, 2026 08:02 ET | Source: Hydrofarm Holdings Group, Inc.

Hydrofarm Holdings Group Announces Fourth Quarter and Full Year 2025 Results

Hydrofarm Holdings Group Announces Fourth Quarter and Full Year 2025 Results
March 27, 2026 08:00 ET | Source: Senti Biosciences, Inc.

Senti Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update

SOUTH SAN FRANCISCO, Calif., March 27, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene...
March 27, 2026 08:00 ET | Source: OnKure Therapeutics, Inc.

OnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Kα Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomalies

-- Financing led by Access Biotechnology with participation from new and existing investors -- Financing to support advancement of two next-generation PI3Kα pan-mutant inhibitors for breast cancer...
March 27, 2026 08:00 ET | Source: PRF Technologies Ltd.

PRF Technologies Provides Year-End 2025 Business Update Highlighting Strategic Progress Across Healthcare and AI-Driven Solar Platforms

LayerBio’s OcuRing™-K program and broader ocular platform strengthen PRF’s healthcare growth strategy DeepSolar advances from acquisition to early commercial deployment TEL AVIV, Israel, March 27,...
March 27, 2026 08:00 ET | Source: NN, Inc.

NN Announces Acquisition to Further Growth in Electric Grid and Data Center

CHARLOTTE, N.C., March 27, 2026 (GLOBE NEWSWIRE) -- NN, Inc. (“NN” or the “Company”) (NASDAQ: NNBR), a global diversified industrial company that engineers and manufactures high-precision components...
March 27, 2026 08:00 ET | Source: Incannex Healthcare

Incannex Reactivates Share Repurchase Program, Underscoring Confidence in Valuation and Strategic Position

MELBOURNE, Australia and NEW YORK, March 27, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies,...
March 27, 2026 08:00 ET | Source: Vor Biopharma

Vor Bio Announces $75 Million Private Placement with TCGX

BOSTON, March 27, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, announced today that it has entered into a...
March 27, 2026 08:00 ET | Source: BTCS, Inc.

BTCS Reports 305% Year-Over-Year Revenue Growth to Record $16.5 Million for Full Year 2025

BTCS Reports Full Year 2025 Financial Results
March 27, 2026 08:00 ET | Source: Sanofi Winthrop Industrie

Press Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma

Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma Recommendation based on positive results demonstrating...